A
- Aminophylline, for asthma
- Antibiotics
- for chronic obstructive pulmonary disease
- for cystic fibrosis
- for pneumonia
- for sore throat
- for upper respiratory tract infection (pneumonia)
- for upper respiratory tract infection (sinusitis)
- Asthma - Drug and Non-Drug
Treatment
- beta-agonists for
- corticosteroids, see steroids
- desensitization
- exacerbations of
- house-dust mite control
- nebulizers
- nedocromil for
- poorly controlled
- primary care of
- salbutamol (as first line drug
treatment)
- salmeterol
- self management teaching programmes
- sodium cromoglycate in
- steroids in
- effective control of symptoms
- repeat daily doses
- short-acting
- with treatment of exacerbations of asthma
- theophylline in
B
- Beta-agonists for asthma
- Bronchiolitis and bronchitis
- antibiotic treatment in
- anti-inflammatory therapy in
- guidelines for
- intramuscular dexamethasone in
- nebulized chromoglycates or budesonide in
- Ribavirin (Tribavirin) treatment in
- passive smoking, association with
- Bronchodilators for chronic obstructive pulmonary disease
- Bronchopulmonary dysplasia of the newborn
C
- Chronic bronchitis and emphysema - drug and non-drug treatment
- antibiotic treatment
- bronchodilators for
- bronchodilators with oral theophylline for
- domiciliary oxygen
- nebulizers for
- pulmonary rehabilitation in
- smoking, effect on
- steroids for
- theophylline for
- Chronic lung disease in the newborn
- prevention with corticosteroid treatment
- prevention with high frequency oscillatory ventilation
- Croup
- budenoside for
- dexamethasone for
- epinephrine for
- treatment in outpatients
- Cystic fibrosis
- antibiotic treatment
- dornase alfa for
- enteric-coated pancreatic enzyme for
- flucoxacillin for
- genetic counselling in
- neonatal screening
- non steroidal anti-inflammatory drugs (NSAIDs) treatment for
- physiotherapy in
- psuedomonas aeruginosa infection in
- screening for
Top
D
- Desensitisation, for asthma
- Dexamethasone for bronchiolitis
- Dornase alfa, for cystic fibrosis
E
- Educational programmes, for people with asthma
- Eformeterol, see salmeterol
- Endotracheal intubation for very low birth weight infants
- Enteric-coated pancreatic enzyme, for cystic fibrosis
F
- Flucloxacillin, for cystic fibrosis
G
- Genetic counselling, for cystic fibrosis
- Guidelines
- asthma
- asthma audit in primary care
- bronchiolitis
- chronic bronchitis and emphysema
- cystic fibrosis
- otitis media with effusion
- pneumococcal vaccination
- pneumonia
- tuberculosis
H
- House dust mite, and asthma
I
- Influenza
- Amantadine for
- immunisation
- in preventing pneumonia
- Rimantadine
N
- Nebulizers
- for asthma
- for chronic obstructive pulmonary disease
- Nedocromil, in asthma
- Non steroidal anti-inflammatory drugs (NSAIDs) treatment for
cystic fibrosis
- Neonatal extracorporeal membrane oxygenation (ECMO), for
respiratory distress in the newborn
- Nitric oxide
- for pulmonary hypertension in the newborn
- for respiratory failure in the newborn
O
Otitis media
- acute, antibiotic treatment
- relative benefit of
- early use of
- association with passive smoking
- with effusion
P
- Persistent pulmonary hypertension (PPHN) in the newborn
- Physiotherapy, for cystic fibrosis
- Pneumonia
- antibiotic treatment
- gram's stain in diagnosis of
- influenza vaccination, effect of
- pneumococcal vaccination, effect of
- Pulmonary rehabilitation, for chronic obstructive pulmonary
disease
R
- Respiratory distress in the newborn
- bronchopulmonary dysplasia
- chronic lung disease
- continuous positive airways pressure (CPAP)
- diaphragmatic hernia, and nitric oxide treatment
- endotracheal intubation
- extracorporeal membrane oxygenation (ECMO)
- high frequency oscillatory ventilation (HFOV)
- nitric oxide inhalation
- use with persistent pulmonary hypertension
- respiratory ventilation
- persistent pulmonary hypertension (PPH)
- pneumothorax, effect of surfactant
- respiratory failure, surfactant therapy
- in care of preterm babies
- using natural surfactant extract
- Ribavirin (Tribavirin) for bronchiolitis
- Respiratory tract infections, see upper respiratory tract
infections
-
S
- Salbutamol for asthma
- Salmeterol for asthma
- Sinusitis
- Smoking
- association with chronic bronchitis and emphysema
- passive, association with bronchiolitis and bronchitis
- passive, association with upper respiratory tract infections
- Sodium cromoglycate for asthma
- Sore throat, antibiotic treatment for
- Steroids
- for asthma
- repeat daily doses
- salbutamol
- salmeterol
- short acting beta-agonists
- for bronchopulmonary dysplasia in the newborn
- for chronic lung disease in the newborn
- for chronic obstructive pulmonary disease
- Surfactant, for premature infants
T
- Theophylline
- for asthma
- for chronic obstructive pulmonary disease
- Tuberculosis
- BCG vaccination
- vulnerable groups
U
- Upper respiratory tract infections
- antibiotic treatment for
- sinusitis
- sore throat
- croup
- in-patients
- out-patients
- otitis media
- antibiotic use with
- with effusion, guidelines
- passive smoking, association with
Health Evidence Bulletins: Wales, Duthie Library, UWCM, Cardiff CF14
4XN. e-mail: weightmanal@cardiff.ac.uk
